DLX5, FGF8 and the Pin1 isomerase control Np63 protein stability during limb development: a regulatory loop at the basis of the SHFM and EEC congenital malformations by Michela, Restelli et al.
DLX5, FGF8 and the Pin1 isomerase control DNp63a
protein stability during limb development: a
regulatory loop at the basis of the SHFM and EEC
congenital malformations
Michela Restelli1,{, Teresa Lopardo1,{, Nadia Lo Iacono1,{, Giulia Garaffo2, Daniele Conte2,
Alessandra Rustighi3, Marco Napoli4, Giannino Del Sal3, David Perez-Morga5, Antonio Costanzo6,
Giorgio Roberto Merlo2 and Luisa Guerrini1,∗
1Department of Biosciences, University of Milano, Milano I-20133, Italy, 2Telethon Laboratory, Department of Molecular
Biotechnologies and Health Sciences, University of Torino, Torino I-10126, Italy, 3Molecular Oncology Unit, LNCIB Area
Science Park, Trieste I-34149, Italy, 4Department of Biochemistry and Molecular Biology, Center for Genetics &
Genomics, and Center for Stem Cell & Developmental Biology, MD Anderson, Houston, TX, USA, 5Laboratoire de
Parasitologie Mole´culaire, IBMM-DBM, Universite´ Libre de Bruxelles, Gosselies B-6041, Belgium and 6Department of
Dermatology, University of Rome ‘Tor Vergata’, Rome I-00133, Italy
Received December 20, 2013; Revised February 20, 2014; Accepted February 20, 2014
Ectrodactyly, or Split-Hand/Foot Malformation (SHFM), is a congenital condition characterized by the loss of
central rays of hands and feet. The p63 and the DLX5;DLX6 transcription factors, expressed in the embryonic
limb buds and ectoderm, are disease genes for these conditions. Mutations of p63 also cause the ectodermal
dysplasia–ectrodactyly–cleft lip/palate (EEC) syndrome, comprising SHFM. Ectrodactyly is linked to defects
of the apical ectodermal ridge (AER) of the developing limb buds. FGF8 is the key signaling molecule in this pro-
cess, able to direct proximo-distal growth and patterning of the skeletal primordial of the limbs. In the limb buds
of both p63 andDlx5;Dlx6murine models of SHFM, the AER is poorly stratified and FGF8 expression is severely
reduced. We show here that the FGF8 locus is a downstream target of DLX5 and that FGF8 counteracts Pin1–
DNp63a interaction. In vivo, lack of Pin1 leads to accumulation of the p63 protein in the embryonic limbs and
ectoderm. We show also that DNp63a protein stability is negatively regulated by the interaction with the
prolyl-isomerase Pin1, via proteasome-mediated degradation; p63 mutant proteins associated with SHFM or
EEC syndromes are resistant to Pin1 action. Thus, DLX5, p63, Pin1 and FGF8 participate to the same time-
and location-restricted regulatory loop essential for AER stratification, hence for normal patterning and skeletal
morphogenesis of the limb buds. These results shed new light on the molecular mechanisms at the basis of the
SHFM and EEC limb malformations.
INTRODUCTION
The p63 gene codes for a transcription factor related to the p53
and p73 tumor suppressor genes, proposed as a master regulator
of epidermal stem cell maintenance and proliferation, able to
promote the epithelial stratification program typical of the
mammalian skin. To date, several mutations in the p63 gene
have been identified associatedwith distinct human developmen-
tal syndromes,characterizedbycommon features suchas limbab-
normalities, ectodermal dysplasia, and facial clefts (1–4). These
syndromes are: the ectodermal dysplasia–ectrodactyly–cleft
palate (EEC, MIM #129900), the ankyloblepharon–ectodermal
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dysplasia–clefting (AEC, MIM #106260), the limb–mammary
syndrome (LMS, MIM #603543), the acro–dermato–ungual–
lacrimal–tooth (ADULT, MIM #103285) and non-syndromic
split-hand/foot malformation type-4 (SHFM-IV, MIM
#605289) (1–4).
p63 homozygous mutant mice show severe defects affecting
their limbs, skin and craniofacial skeleton (5–7). In p632/2
newborn animals, the hindlimbs (HLs) are absent whereas the
forelimbs (FLs) are severely truncated in their distal segment.
The limb defects of p632/2 mice have been associated with
failure of stratification and signaling of the cells of the apical
ectodermal ridge (AER), a transitory specialization of the ecto-
derm at the dorsal–ventral border of the limb bud, essential for
proximo-distal growth of the limbs and patterning of the
fingers (8–10). p63 is expected to control AER function and
maintenance via transcriptional regulation of AER-restricted
target genes (2,11,12). Failure of AER stratification has also
been associated with loss of expression of key morphogens for
limb development, such as FGF8 and Dlx genes (2).
Within the EEC disease phenotype, ectrodactyly (also known
asSHFM, MIM #183600) is a recurrent finding and consists in
the absence of the distal portion of the central rays of upper
and lower limbs, resulting in a deep medial cleft, missing or
hypoplastic central fingers and fusion of the lateral ones. In
addition to be part of the EEC syndrome, SHFM comprises
both sporadic and hereditary forms, syndromic or isolated,
linked to six distinct loci (types I–VI) (2,13–15). The most
common form, SHFM type-I, is associated with deletions of
variable extent on chromosome 7q21, the minimal common
deletion includes DSS1 and the homeogenes DLX5 and
DLX6 (16,17). Recently, a point mutation in the DNA-binding
domain of DLX5 (Q178P) has been reported in a SHFM-I
family with a recessive transmission, co-segregating with
the limb malformations (18). In the mouse, the double knock-
out (DKO) of Dlx5 and Dlx6 leads to an ectrodactyly pheno-
type affecting the HLs (19,20), fully confirming that the
human orthologs DLX5 and DLX6 are the disease genes for
this malformation.
SHFM type-IV (MIM #605289) is caused bymutations in the
p63 gene. In 50 unrelated patients with isolated SHFM, 5 muta-
tions in p63 were found, suggesting that these may account for
10% of sporadic cases of SHFM (1,4,21). Finally, SHFM
type-III (MIM #246560) is linked to abnormalities of a
genomic region comprising dactylin and several other genes,
in mice and man; however, no disease gene has convincingly
been demonstrated, as to date (22–24). Notably, the FGF8
locus resides in the SHFM-III region; thus, this gene may repre-
sent a valid candidate for SHFM type-III (2).
Several studies have attempted to define p63-dependent tran-
scription regulatory networks (25,26) with the hope to identify
core genes and regulation at the basis of normal ectoderm devel-
opment anddifferentiation, aswell as to provide clues on themo-
lecular bases of the ectodermal phenotypes in the EEC.
Specifically, ectrodactyly has been linked to the ability of p63
to regulate transcription of Dlx5 and Dlx6, both in vitro and in
the developing embryonic limbs (7). This regulation takes
place both at the proximal promoter level and via a conserved
cis-acting genomic element, located 250 kb centromeric to
DLX5, that is deleted in a family with SHFM type-I (25). Thus,
the Dlx5 and Dlx6 genes are true p63 transcriptional targets,
whose regulation during limb development is presumably
needed to maintain the specialization and stratification of the
AER cells (2,7).
While the pathways downstream of p63 are beginning to be
elucidated, our knowledge on the upstream regulations of p63
isminimal. Themain questions that arise are: how is p63 expres-
sionmaintained in (proliferating) ectodermal stem cells?How is
p63 down-modulated in differentiating cells? How are changes
in p63 level linked to loss of AER stratification and the onset
of the SHFM phenotypes? Recently, one such regulation has
been identified and consists in a loop-like regulation between
p63 and IRF6 (27). Several biochemical observations suggest
that the DN- and TA-p63 proteins are tightly regulated at post-
translational level, via protein modification (phosphorylation,
sumoylation and ubiquitination) and protein–protein interac-
tions (28–30).
Here we show that the prolyl cis/trans isomerase Pin1 acts an
additional regulator of p63 protein stability, inducing a
phosphorylation-dependent, proteasome-mediated degradation
of wild-type (WT) DNp63a, but not of a disease-causing p63
mutant. Conversely, FGF8 appears to counteract Pin1-induced
p63 degradation, and thus to promote p63 stability by inhibiting
the interaction ofDNp63awith Pin1, in vivo. As theFGF8 locus
appears to be regulated by both p63 and DLX5, we propose a
model in which these two SHFM-causing genes and FGF8
take part in a regulatory loop that opposes Pin1-mediated
degradation of p63, hence permitting stratification and special-
ization of ectoderm cells into the AER, in a time and region-
restricted manner during limb development. In SHFM type-I,
type-III and type-IV, such regulation is impaired leading to
reduced AER stratification, limb malformation and skeletal
defects.
RESULTS
The AER of Dlx5;Dlx6 DKO embryos is poorly stratified
Mutations in DLX5 or complex genomic alterations around the
DLX5;DLX6 locus cause, in human, the malformation known
as SHFM type-I (16,18). In mice, the combined deletion of
Dlx5 andDlx6 (Dlx5;Dlx6DKO) causes a limb phenotype iden-
tical to human SHFM-I and is accompanied by reduced expres-
sion of FGF8 in the AER cells (19,20). Thus, the Dlx5;Dlx6
DKO mice represent a valid animal model for SHFM-I, and
we set forth to use them to examine whether the loss of
Dlx5;Dlx6may result in altered AER stratification.
We stained sections of WT and Dlx5;Dlx6 DKO HL, at the
ages E11.5 and E12.5, with anti-E-cadherin antibody and exam-
ined the stratification of the AER cells. We specifically focused
on the central wedge of the AER, because previous publications
have indicated that only this wedge loses expression of FGF8,
Bmp4, Msx2 and Dlx2 (2,19,20,31 and our unpublished data).
At earlier ages (E11.5), the organization of the Dlx5;Dlx6
mutant AER appeared very similar to the WT (not shown),
whereas at later ages (E12.5), the central wedge of the
Dlx5;Dlx6 mutant AER appeared less stratified compared with
the equivalent region of the normal limbs (sectors 2 and 3,
Fig. 1B). Notably, in more lateral regions of the AER (sector
1), the stratification was normal.
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To further document this finding, we carried out scanning
electron microscopy (SEM) on the AER of normal and
Dlx5;Dlx6 DKO limbs at the age E12.5 and observed that the
cells of the central wedge of the Dlx5;Dlx6 mutant AER
appeared morphologically abnormal, with an increase in the
length of the maximum diameter (10.8+ 2 versus 19.7+ 4.3;
P, 0.03), more irregular borders and fewer microvilli on the
apical surface (compare Fig. 1E with D).
Thus, between E11.5 and E12.5, in the absence of Dlx5 and
Dlx6, the central wedge of theAER fails to specialize into a plur-
istratified epithelium. Notably, we and others have previously
shown that theAERof p63-null and of p63-R279H homozygous
mutant limbs is poorly stratified, and this is accompanied by
reduced FGF8 expression and the appearance of severe limb
defects (5–7).
The AER of Dlx5;Dlx6 DKO limbs shows reduced levels of
DNp63a
We decided to further investigate the molecular link connecting
Dlx5;Dlx6 andp63 in theembryonic limbs.Wepreviously estab-
lished that the expression of DNp63 and TAp63 mRNAs is not
significantly changed in the Dlx5;Dlx6 DKO limbs (7), and we
also excluded changes in Pin1mRNA or protein levels (Supple-
mentaryMaterial, Fig. S1). Thus, we ruled out a direct transcrip-
tional regulation for the observed reduction of p63 in the
Dlx5;Dlx6 DKO limb buds (Fig. 2) and opted for a post-
transcriptional type of regulation.
Considering that p63 is essential for stratificationof ectoderm-
derived epithelia, we set forth to determine whether the absence
ofDlx5;Dlx6may lead to altered levels of p63protein in theAER
cells of the developing limb buds. We carried out immunostain-
ing for p63 on serial sections of the HLs, focusing on the central
wedgeof theAER, and semi-quantified the signal intensity along
the anterior-to-posterior length of the limb bud (schemes in
Fig. 2D and E). In the AER nuclei of the central wedge
(sectors 2 and 3, Fig. 2B), p63 immunostaining is significantly
reduced as compared with the same region of the normal limb
(sector 2, 250%; sector 3, 265%), whereas no such difference
was observed in lateral wedges of the AER (sector 1) or in the
non-AER ectoderm (Fig. 2A and B, quantification in C).
Thus, p63 is down-regulated in the central AER cells by post-
transcriptionalmechanisms, at the same time as these cells fail to
efficiently stratify. As p63 has been directly linked to ectodermal
stratification (11), we can hypothesize that the mis-organization
of the AER cells in Dlx5;Dlx6 DKO limbs might be the conse-
quence of altered p63 levels.
Pin1 interacts withDNp63a andpromotes its destabilization
The stability of the p63 protein is tightly regulated by the action
of several interacting or modifying proteins, including MDM2
and p53 (28–30). The enzyme peptidyl-prolyl cis/trans isomer-
ase NIMA-interacting-1, Pin1, has been shown to modulate the
activity of p53 and p73 by post-translational modifications
(32–36). We therefore examined the possibility that Pin1 may
Figure 1. Impaired AER stratification in the limbs of Dlx5;Dlx6 DKO mutants. (A–C) Immunofluorescent staining on WT and Dlx5;Dlx6 DKO HLs, to detect
E-cadherin (green), on serial transverse sections of the limbs, at E11.5. White arrows indicate the extension of the AER ectoderm. The position of the section
planes of the micrographs (in A and B) along the anterior-to-posterior (1, 2, 3) are show in C. Scale bar in A ¼ 20 mm. (D,E) SEM of the surface of the AER cells
of WT (D) and Dlx5;Dlx6 DKO (E) limbs. The mutant AER cells appear larger, show fuzzy borders and nearly lack microvilli. Scale bar in D ¼ 10 mm. (F) Quan-
tification of the size of AER cells (maximum cell length) comparingWT versusDlx5;Dlx6DKOmutant specimens. TheWTwas used for normalization andmade to
1. P , 0.02.
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also regulate DNp63a protein level and consequently modulate
its activity, by a similar mechanism. Notably, previous experi-
ments have shown a diminished transcription of two p63
targets in Pin1-overexpressing cells in vitro (37), suggesting
that Pin1 could modulate p63 protein levels and/or activities.
To verify this point, we adopted an siRNA-based approach to
down-regulate endogenous Pin1 expression in the U2OS human
osteosarcoma cell line, which does not express p63 endogenous-
ly.We transfected theU2OScellswithDNp63a and an anti-Pin1
siRNA. The depletion of Pin1 resulted in a significant stabiliza-
tion of DNp63a, as compared with control-silenced cells
(Fig. 3A). Conversely, overexpression of Pin1 resulted in a
marked and dose-dependent reduction of DNp63a protein
levels (Fig. 3B). The same experiment was performed on the
A431 human epidermoid squamous carcinoma cell line, which
expresses DNp63a endogenously and yielded similar results
(data not shown).
We then tested whether disease-causing mutant p63 proteins
are sensitive to the degrading action of Pin1, by transfecting ex-
pression vectors carrying the L518F (linked to AEC syndrome),
the DAA (linked to LMS syndrome) or the E639X (linked to
SHFM-IV syndrome) point-mutated variants. While the AEC
mutant p63 protein was still sensitive to Pin1-induced degrad-
ation, the LMS and SHFM mutants were more resistant to such
effect (Fig. 3C). Interestingly, while the AEC syndrome is not
associated with limb developmental defects, the LMS and
SHFM syndromes typically entail an ectrodactyly phenotype.
We then tested whether the effect of Pin1 on p63 might be
mediated by the proteasome. U2OS cells were co-transfected
with a Pin1 and a DNp63a expression vectors and then treated
with the proteasome inhibitor MG132; we observed that the
Pin1-induced depletion of DNp63a was partially reversed in
MG132-treated cells, compared with controls (Fig. 3D), sug-
gesting that Pin1-induced p63 protein destabilization is in part
mediated by the proteasome.
We then examined whether Pin1 and p63 proteins physically
interact in vivo. We carried out co-ImmunoPrecipitation (co-IP)
experiments in HaCaT cells, which express both proteins en-
dogenously, using anti-Pin1 and anti-p63 antibodies. co-IP
with the anti-p63 antibody was able to pull down Pin1, and
vice versa, indicating that these two proteins interact, either dir-
ectly or indirectly via complex formation (Fig. 3E). Pin1 is
known to interact with its partner proteins in a phosphorylation-
dependent manner and to catalyze cis/trans isomerization of
Figure2.p63protein level is reduced inDlx5;Dlx6mutantAERcells. Immunofluorescent detectionof p63 in the nuclei of theAERofWTandDlx5;Dlx6DKOlimbs,
at the age E11.5. (A,B) Micrographs of WT (panels in A) andDlx5;Dlx6mutant (panels in B) sections, corresponding to the positions (1, 2, 3 and 4) indicated in E.
White arrows indicate the extensionof theAER.Scale bar inA ¼ 20 mm. (C) Semi-quantitative assessment of p63 signal in theAERofWT(openbars) andDlx5;Dlx6
mutant (graybars), expressedas intensityper100nuclei, in arbitraryunits.The results showthatp63staining is significantly reduced (250%) in thepositions2and3of
theAER of themutant limbs, relative to theWT. (D,E) Schemes illustrating thewedge of the AER relevant for the SHFMphenotype (yellow inD) and the position of
the section planes (1, 2, 3 and 4) along the anterior-to-posterior axis (red rectangles in E). The numbers on the left of each section plane indicate the distance from the
anterior margin.
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Figure 3. The Pin1 isomerase promotes DNp63a degradation. (A) Western blot analyses of whole protein extracts of U2OS cells transiently co-transfected with
DNp63a (50 ng) and an anti-Pin1 siRNA (10 pmol/cm2), or an anti-LacZ siRNA (siCtr 10 pmol/cm2) as negative control. Actin is used for loading control. (B)
Western blot analyses of whole protein extracts from U2OS cells transiently co-transfected with increasing amounts (20, 40 and 80 ng) of Pin1–HA-tagged
vector (indicated on top), andWTDNp63a (30 ng). Thea-isoform is efficiently degraded by Pin1 expression, whereas theb- and the g-isoforms are not (Supplemen-
taryMaterial, Fig. S1). (C)Western blot analyses of whole protein extracts fromU2OS cells transiently co-transfected with increasing amounts (20, 40 and 80 ng) of
Pin1–HA-tagged vector (indicated on top), and the disease-relevant mutated versions of DNp63a L518F (AEC associated), DAA (LMS associated) and E639X
(SHFM associated) (30 ng each) (indicated at the bottom). Actin is used for loading control. The mutant p63 proteins linked to congenital limb malformations
(LMS and SHFM) are relatively resistant against Pin1-induced degradation, compared with WT p63, whereas the mutant p63 linked to AEC, with no limb
defects, is sensitive to Pin1. (D) Western blot analyses of whole protein extracts from U2OS cells, transiently co-transfected with DN-p63a and Pin1–HA-tagged
expression vectors, and 20 h later either treated with 5 mM of the proteasome inhibitor MG132 or left untreated (DMSO only). Proteins were extracted after 5 h of
treatment and assayed by western analysis; actin is used for loading control. On the right, quantification of the p63 protein level, expressed as the ratio between
the treated and the untreated sample, in cell transfected (gray bar) or not transfected (open bar) with Pin1. The results show that Pin1-mediated destabilization of
p63 ismainlymediatedby theproteasome. (E)Westernblot analyses of proteins immunoprecipitatedwith anti-p63 (IPp63)or anti-Pin1 (IPPin1) antibodies, revealed
using, respectively, anti-Pin1 (bottom, lanes) and anti-p63 (top panel). Input control is shown on the left. (F)Western blot analysis of GST-pull down assay donewith
anti-Pin1, revealedwith anti-p63antibody, in thepresence (+lPPase, on the right) or absence (2lPPase, on the left) of proteinphosphatase during thepull-down.The
input sample is also loaded as control. While untreated samples contained p63, in the presence of IPP the p63 protein is absent.
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selected peptide bonds (38). Therefore, we tested whether the
Pin1–p63 interaction might depend on phosphorylation. We
transfected the U2OS cells with DNp63a and then detected the
interacting proteins by using GST-WW (or GST as a control),
in the presence or absence of l-phosphatase, as previously
described (39). Treatment of the cell lysates with l-phosphatase
resulted in a loss of the interaction between Pin1 and p63
(Fig. 3F), suggesting that this interaction requires a phosphoryl-
ation event.
Absence of Pin1 results in increased levels of DNp63a
protein in vivo
We next sought evidence that Pin1 regulates p63 protein levels
during embryonic development, and specifically in the embry-
onic ectoderm. We collected samples of ectoderm and limb
buds from E11.5 WT and Pin12/2 embryos (40,41) and
stained sections with an anti-p63 antibody that recognizes all
p63 isoforms. Of note, the DNp63a isoform is the most abun-
dantly expressed in the limb buds at this age (7). The results
show that the intensity of p63 immunostaining in the nuclei
was increased both in the AER (Fig. 4B) and the non-AER
(Fig. 4D) ectodermofPin12/2 embryos, 4- and 3-folds, respect-
ively, relative to the WT (Fig. 4A and C).
As p63 IFL signal was found to be reduced in the Dlx5;Dlx6
DKO limbs (Fig. 2), we asked whether this was due to increased
Pin1 expression, either mRNA or proteins. Thus, we stained ad-
jacent sections ofWT andDlx5;Dlx6DKO limbs with anti-Pin1
antibody, but no significant difference in the Pin1 signal was
detected in the mutant limbs (Supplementary Material, Fig.
S2). Antibody specificity was confirmed by complete lack of
staining in Pin1 KO embryonic limbs. We also determined the
mRNA abundance of Pin1 mRNA in RNA extracted from WT
or Dlx5;Dlx6 DKO limbs, by Real-Time qPCR, but again
could not detect any significant differences (SupplementaryMa-
terial, Fig. S2). Thus, we concluded that the reduced p63 levels
observed in the Dlx5;Dlx6 DKO AER cells are unlikely to be
due to changes in Pin1 level.
FGF8 is downstream of DLX5 and counteracts
Pin1-dependent degradation of p63
We decided to further investigate the molecular link connecting
Dlx5;Dlx6andp63 in the embryonic limbs.Wepreviously estab-
lished that the expression of DNp63 and TAp63 mRNAs is not
significantly changed in the Dlx5;Dlx6 DKO limbs (7), and we
also excluded changes in Pin1mRNA or protein levels (Supple-
mentaryMaterial, Fig. S1). Thus,we excluded a direct transcrip-
tional regulation for the observed reduction of p63 in the
Dlx5;Dlx6 DKO limb buds (Fig. 2) and opted for a post-
transcriptional type of regulation.
Figure 4. Loss of Pin1 causes stabilization of p63 in the embryonic ectoderm. (A–D) Immunofluorescent detection of p63 on the AER ectoderm (A,B) and the
non-AER ectoderm (C,D) of WT (A,C) and Pin1 KO (B,D) embryonic limbs, at the age E11.5. White arrows in A–C indicate the extension of the AER ectoderm.
IFLsignal is specifically detected in the nuclei. (E,F) Semi-quantitative assessment of p63 signal in theAER (E) and the non-AERectoderm (F), expressed as intensity
per 100 nuclei, in arbitrary units.Wild-typewas normalized andmade to 1. In the absence of Pin1, the p63 signal is increased4-folds in theAER, and3-folds in the
general ectoderm. (G) A scheme to illustrate the approximate position of the section planes in A–D, along the anterior-to-posterior axis. The AER and non-AER
ectoderm are highlighted in yellow. Scale bar in B ¼ 20 mm.
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In theAERof bothDlx5;Dlx6DKOandp63mutant limbs, ex-
pression ofFGF8 is reduced, as revealed by in situ hybridization
(5,6,19). FGF8 is a well-known limb morphogenetic diffusible
factor, essential for the maintenance of AER stratification, for
limbgrowth andmorphogenesis (42–44), and thepartial or com-
plete absence of members of the FGF family causes a set of de-
velopmental limb defects (42,45). Thus, we focused on FGF8
and raised the hypothesis that Dlx5 and/or p63 may concur to
positively regulate FGF8 transcription (2).
First, we quantified the expression of FGF8, Pin1 andDNp63
in the HL and FL of WT and Dlx5;Dlx6 mutant embryos, by
Real-Time qPCR, and observed that FGF8 expression in the
mutant limbs is reduced by 40%, compared with the normal
limbs (Fig. 5A), whereas expression of Pin1 and of p63 did not
significantly change. This result confirms previous in situ hy-
bridization data showing reduced expression of FGF8 in the
central wedge of the AER ofDlx5;Dlx6DKOHLs (19) (our un-
published data). Notably, a reduction of FGF8 mRNA abun-
dance was also seen in the embryonic FLs of Dlx5;Dlx6 DKO
embryos, showingnoevident developmental defects, suggesting
that the down-modulation of FGF8 is not the mere consequence
of cell suffering, but more likely a transcriptional misregulation
occurring in both the HLs and the FLs.
The FGF8 locus lies in a genomic region that has previously
been implicated in the SHFM type-III malformation in human,
and to an ectrodactyly phenotype in the dactylaplasia mouse
strain (22,23). Currently, the disease gene causing this malfor-
mation is uncertain, but there is evidence suggesting that the
underlying genetic mechanism is a genomic position effect. p63
binding sites have been detected in this region, via ChIP-seq
experiments on human keratinocytes (25). We searched the
FGF8 locus and flanking regions for the presence of predicted
Dlx5 binding sites, conserved between mouse and human, using
a position–weightmatrix (PWM) approach (31,46), and detected
four such sites (Fig. 5B, and Supplementary Material, Fig. S3).
ToverifywhetherDLX5physically interactswith thesegenomic
elements, we carried out ChIP analyses on two of these regions,
named DBE-1 and DBE-2, located, respectively, 1 kb down-
stream of FGF8 (DBE1) and within the first intron of dactylyn
(DBE2) (Fig. 5B). We transfected U2OS cells with the DLX5-
myc-tag expression vector, and with an empty vector as control,
and then immunoprecipitated the chromatin with anti-myc-tag.
Figure 5. FGF8 is regulated by Dlx5. (A) Relative abundance of FGF8, Pin1 andDN-p63mRNAs in samples fromWT (gray bars) andDlx5;Dlx6DKO (black bars)
HLs and FLs.Values are expressed relative to theWT specimen, whichwas set to 1. TheDlx5mRNA level is used to confirm themutant genotype. Experimentswere
done on independent biological duplicates. (B) Scheme of the FGF8 andDactylyn loci, showing the SHFM-III critical region and the approximate position of the two
best predicted Dlx5 sites DBE-1 and DBE-2, indicated with black arrows (31). The exact (human or mouse) sequence corresponding to the DBE-1 and -2 sites is
reported in open boxes; the bold characters represent the Dlx5 PWM (46). Solid boxes represent the exons. The position of p63 binding sites [from (25)] is reported
in SupplementaryMaterial, Fig. S3. (C) ChIP analysis on the chromatin of U2OS cells, transfected with DLX5-myc-tagged and immunoprecipitated with anti-myc.
TheDBE-1 (left) andDBE-2 (right) elementswereamplifiedbyPCR.Enrichment isdetected incells transfectedwithDLX5,comparedwithmock-transfectedcells, or
with chromatin precipitatedwith an irrelevant antibody (IgG). Input chromatin is shown of the left of each blot. (D) Relative abundance of endogenous FGF8mRNA
upon transfection of U2OS cells with the WT (light gray bar) or the Q178P mutant (dark gray bar) DLX5-HA expression vectors. Values are expressed relative to
sample from control transfected cells (open bar), set to 1.
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The results show an enrichment of the DBE-1 and DBE-2 ele-
ments in the presence of DLX5-myc protein, compared with
the negative controls (Fig. 5C).
Next we asked whether overexpression of DLX5 in U2OS
cells (not expressing DLX5 endogenously) indeed resulted in
higher FGF8 mRNA levels. We carried out Real-Time qPCR
on RNA extracted from U2OS cells transfected with either the
WT DLX5 or the Q178 mutant DLX5 expression vectors and
measured the abundance of endogenous FGF8mRNA. Expres-
sion of WT DLX5 resulted in a 1.7-fold increase in FGF8
mRNA, whereas the mutant DLX5 protein had a minimal
effect on FGF8 expression levels (Fig. 5D). Together, all these
data indicate that FGF8 is a transcriptional target of DLX5 and
that the SHFM-linked DLX5-Q178P mutant, linked to SHFM-I,
looses the capacity to efficiently activate FGF8 expression.
Next we investigated bywhichmechanism FGF8 participates
in Dlx5-Pin1-p63 regulatory loop, by investigating the effect of
FGF8 on the stability/degradation of p63.We transfected U2OS
cellswith thePin1-HA-tag expressionvector and then treated the
cells with either purified FGF8 or with DMSO as negative
control.While in the absence of exogenous FGF8, Pin1 could ef-
ficiently down-modulateDNp63a protein levels, in the presence
of FGF8 this effect was reduced (Fig. 6A). Similar results were
obtained by treating U2OS cells with FGF2 (data not shown).
Interestingly, treatmentwithFGF8 alone resulted in increased
levels of DNp63a. These results indicate that FGF8 counteracts
the ability of Pin1 to induce DNp63a, degradation.
In order to reveal by which molecular mechanism FGF8 pre-
vents Pin1-mediated degradation ofDNp63a, we tested by co-IP
whether FGF8 could modulate Pin1-DNp63a protein–protein
interaction, in vivo. In the presence of recombinant FGF8,
DNp63a–Pin1 interaction was significantly reduced compared
with the interaction detected in the absence of FGF8 (Fig. 6B).
Finally, as binding of Pin1 to its target protein is known to be de-
pendent on phosphorylation of serine/threonine residues, we
verified the phosphorylation status of DNp63a in untreated
versus FGF8-treated cells by using anti-phospho serine and
threonine antibodies on immunoprecipitated DNp63a from
HaCaT cells. A reduction of basal serine phosphorylation
levels of DNp63a was evident upon FGF8 treatment (Fig. 6C).
Similar results were obtained with anti-phospho threonine anti-
bodies (data not shown).
These results suggest that FGF8 protectsDNp63a from Pin1-
dependent degradation by interfering with the ability of Pin1 to
physically interact with DNp63a.
DISCUSSION
p63 is emerging as themaster transcriptional regulator of expan-
sion, development and differentiation of ectoderm-derived cells
and tissues. Great attention has been placed on the identification
of its downstream transcriptional targets (25,26,47); however, an
equal complex set of regulations controls the p63 level, stability,
activity, and degradation (28–30). The increasingly complex
regulation upstream and downstream of p63 reflects the peculiar
and critical activity of p63 to finely orchestrate the timing of exit
from the cell cycle and the dynamic of stratification of mamma-
lian ectoderm (27,48).
Ectodermal dysplasias are often accompanied by limbmalfor-
mations, and specifically the p63-linked EEC comprises the
ectrodactyly (SHFM) phenotype, with varying degrees of pene-
trance and severity. Six loci have been identified in hereditary
forms of SHFM, and additional SHFM loci might exist to
account for sporadic cases. For type-I and –IV, the transcription
factors DLX5-DLX6 and p63, respectively, are the recognized
disease genes (18,49). For SHFM-III, the F-box/WD40 gene
Dactylin has been proposed (22–24). In the recessive form
SHFM type-VI, the WNT10b gene has recently been found
mutated (15). The existence of several phenocopies of ectrodac-
tyly has long suggested the possibility that the corresponding
disease genes might participate in a regulatory cascade;
however, the only established link is the transcriptional regula-
tion of p63 on Dlx5;Dlx6 (7,25,50). By examining the murine
models of SHFM available to date, namely the p63null, p63EEC
(for SHFM-IV and EEC), the Dlx5;Dlx6 DKO (for SHFM-I)
and the spontaneous mutant strain Dactylaplasia (Dac, for
SHFM-III), the striking observation is that in all these models
the AER shows reduced FGF8 expression and lack or has
impaired stratification, with accompanying limb developmental
defects of varying severity (5–7,19,20,51).
Figure 6. FGF8 counteracts Pin1-induced p63 degradation. (A) Western blot analysis of total protein extracts from U2OS cells co-transfected with the DNp63 ex-
pression vector (30 ng) and the Pin1–HA-tagged expression vector (40 ng) and either treated for 3 h with 1 ng/ml of recombinant FGF8 or left untreated (DMSO
only). In the presence of FGF8, Pin1-induced p63 degradation is significantly less efficient. (B) Extract from HaCaT cells, either treated with 1 ng/ml of FGF8 or
left untreated (DMSOonly), immunoprecipitatedwith anti-p63polyclonal antibody (p63H-129,SantaCruz) and analyzedbywestern blotwith either p63monoclonal
antibody or Pin1monoclonal antibody. Input (no IP) is shown on the top. U2OS cells not expressing endogenous p63were used as negative control. In the presence of
FGF8, Pin1 is no longer able to interact and co-immunoprecipitate p63. (C) Extract from HaCaT cells, either treated with 1 ng/ml of FGF8 or left untreated (DMSO
only), immunoprecipitated with anti-p63 and analyzed by western blot witha-phospho-ser. In the presence of FGF8, the amount of serine phosphorylation is clearly
diminished.
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Here we show that the Pin1 cis/trans isomerase is a regulator
of p63 protein stability, inducing proteasome-mediated degrad-
ation ofDNp63a.We also show that FGF8 counteracts this func-
tion and thus promotes p63 stability. The FGF8 locus appears to
be regulated by DLX5; thus, we propose a model (see Fig. 7) in
which these two SHFM disease genes, together with FGF8 and
FGFR1, take part in a regulatory loop that tightly controls p63
protein level. According to our model, the activation of this
loop permits stratification and specialization of ectoderm cells
into the AER, in a time and region-restricted manner during
limb development. In SHFM type-I, type-III and type-IV, such
regulation is impaired leading to reduced AER stratification,
limbmalformation and skeletal defects. Although somemolecu-
lar details still remain to be fully clarified, our novel findings to-
gether with previous work from our team (7) provide a
developmental andmolecular explanation for a set of congenital
limb malformations.
Our model helps to explain other observations and findings.
The FGF8 locus is located close (50 kb) to the chromosomal
region implicated in SHFM type-III and in the Dac mice. Al-
though Dactylyn has been proposed as the disease gene for
these malformations (22–24), no clear evidence is available
on its role in limb development. Conversely, there are reasons
to implicate FGF8 in themolecular pathogenesis of this disorder.
First, the SHFM-III/Dac rearrangement does not interrupt any
gene, and therefore, it is likely to act by perturbing the chromo-
somal organization and affecting expression of nearby genes;
second, the FGF8 expression is reduced in the limb buds of
Dlx5;Dlx6, p63null, p63EEC and Dac mutant embryos (5–
7,19,22) (and this report); third, the presence of Dlx5 (this
report) and p63 (25) binding sites in conserved genomic
regions near the FGF8 and the Dactylyn loci; fourth, FGF8
plays a critical role for limb bud growth, patterning,morphogen-
esis aswell asAERmaintenance (9,42,51–53). Thus, it is tempt-
ing to propose that misregulation of FGF8 expression is the
molecular lesion at the basis of SHFM-III/Dac; however,
direct evidence for this is lacking and should be explored in
future works.
The role of FGF8 in the signaling from the AER for the prox-
imal limb development iswell known (45,52), however not fully
comprehended in cellular terms. The AER-specific conditional
disruption of FGF8 does not lead to altered AER induction
and stratification, per se (54); however, this could be explained
by the fact that during limb development, FGF4, FGF9 and
FGF17 have been shown to compensate for the loss of FGF8
(45). Conversely, the AER-specific conditional disruption of
Fgfr2 leads to altered AER stratification and function and limb
defects (55). AER-derived FGFs have been shown to promote
non-directional mesenchymal cell movements during limb bud
morphogenesis (44),andconsistently, theconditional inactivation
ofFgfr1 in the limbmesodermdisrupts the relative proportions of
the limb elements and leads to profound limbmalformations (56).
Most relevant, mutations in FGFR1 have recently been found in
patients with Hartsfield syndrome (OMIM 615465), a congenital
condition comprising ectrodactyly (57). This finding clearly sup-
ports the notion that impairment of the FGF signaling is directly
involved in the molecular pathogenesis of ectrodactyly.
While FGFs promote mesenchymal cell movements, in the
same article the authors show that Wnt5a promotes oriented
cell divisions/movements during limb development (44), and
Wnt5a is a known target ofDlx5 (58).Webelieve that these find-
ings are highly relevant for the comprehensionof theSHFMmal-
formation, and we are tempted to speculate that the reduced
expression of FGF8 and Wnt5a (our unpublished data) in the
central AER ofDlx5;Dlx6DKO limbs may induce mis-oriented
divisions/movements of mesenchymal cells in this sector, hence
altered morphogenesis/loss of central digits. This possibility
warrants future experimental work. When a more complete
model will be available, the hope is to be able to exploit this
knowledge to restore normal levels of these soluble signaling
factors, toward correcting the SHFM defects.
AlteredPin1-dependent p63 regulationmay impact on several
cellular processes, in addition to ectoderm stratification. Cells
from Pin1 knock-out mice have difficulties in exiting the G0
and entering the S phase, and Pin1 null animals have meiotic
defects and are hypofertile (40,41). In these animals, an altered
phosphorylation levels of RB correlate with tumor growth
(59). However, as Pin1 interacts with p53 and p73, the contribu-
tion of p63 is uncertain. Likewise, a Pin1/mutant p53 axis has
been identified that promotes aggressiveness of breast cancer
cells; however, the relevance of p63 in this context is not well
defined (37). A role for p63 has been established in cancer
types of ectodermal or endodermal origin, in particular lung
and skin carcinomas. Indeed, DNp63a regulates keratinocyte
proliferation by controlling PTEN expression and localization
(60). Notably, a mis-activation of p63 in squamous cell carcin-
omas has been functionally linked with the activation of the
FGFR2 receptor (61), further supporting the view that FGFs par-
ticipate in Pin1-dependent p63 stability.
It would be important to define whether this regulatory path-
way participates in skin carcinogenesis.
MATERIALS AND METHODS
Mouse strains
The Dlx5;Dlx6 DKO mouse strain (20) was maintained in a
mixed C57/BL6:DBA genetic background. The Pin1 null
mouse strain was originally generated by Fujimori and cowor-
kers (40), then transferred onto a C57/BL6 pure background
by Atchison and coworkers (41) and maintained in this back-
ground. The day of the vaginal plugwas considered as embryon-
ic age 0.5. Embryos were collected at the indicated ages in cold
PBS, fixed in cold 4% PFA for 8–12 h and processed for cryo-
preservation and sectioning according to standard protocols.
Extra-embryonic tissues were used for genotyping by PCR.
Immunofluorescence on embryonic limbs
Longitudinal sections of 12–15 mm were collected on glass
slides, blocked with PBS with 1% BSA for 1 h at RT and incu-
bated with the following primary antibodies, diluted from 1 :
250 to 1 : 50 in PBS + 1% BSA, ON at 48C: anti-Pin1 (G8
sc-46660, Santa Cruz), with anti-p63 (4A4 sc-8431, Santa
Cruz) and with anti-E-cadherin (36/E 610182, BD) and then
incubated with secondary antibodies anti-mouse-Cy2 and
anti-rabbit-Cy3 (Jackson ImmunoResearch) diluted 1 : 200,
1 h at RT, washed, stained with DAPI for the nuclei detection
and examinedwith a ZeissObserver-Z1 fluorescentmicroscope,
equipped with Apotome system. Raw images were digitally
3838 Human Molecular Genetics, 2014, Vol. 23, No. 14
 at U
niversita degli Studi di Torino on June 30, 2014
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
Figure 7.Model of the molecular loop between Dlx5 and p63 during AER stratification. Our proposed model of the regulatory loop linking the Dlx5 and the p63
SHFM-genes, via the activity of Pin1. (A) In WT AER cells, Dlx5;Dlx6 positively control FGF8 transcription, a function most likely shared with Dlx1 and Dlx2
[see ref. (2)]. Likewise, p63 also activates FGF8 transcription, acting on independent genomic elements. AER-expressed FGF8 acts on the AER cells and prevent
Pin1-inducedDNp63proteindegradation: suchfinemechanismdynamicallymaintains a control over the level of p63 in theAERcells, to assure their time- and region-
restricted ability of these cells to stratify. (B)Mutation or loss ofDlx5 yield to a reducedFGF8 expression and an augmented ability of Pin1 to induce p63 degradation.
Consequently,DNp63 tends tobedepleted in theAERnuclei,whichmay result in a furtherdown-modulationofFGF8.ReducedFGF8andp63cause impairment in the
ability of theAERcells to stratify. (C)Mutant p63 associatedwith congenital limbmalformations in human (LMSand SHFM) are relatively resistant to Pin1-induced
degradation, although theyappear tobe transcriptionally inactive.Solidarrows indicateactivation; solid stamps indicate repression.Linewidthsareproportional to the
intensity and/or efficiency. Transcription factors are frames in squares; the other genes are framed in ovals.
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processed to normalize the background and optimize the con-
trast, with Photoshop (Adobe), and mounted with QuarkXpress
(Pantone).
Semi-quantitative immunofluorescence analysis was per-
formed with ImageJ-64 (v1.45) software. Images were first con-
verted to grayscale, and the DAPI channel was used to count
nuclei. p63 intensity was quantified after background correction
and normalized respect to the number of nuclei in the region of
interest.Data arepresented asmeanand s.d. of4/5different sec-
tions of three different embryos. A significant T-test score is indi-
cated by asterisks: ∗indicates P, 0.05, ∗∗indicates P, 0.01.
Plasmids
Vectors expressing the WT DNp63a isoform of, or the disease-
linked mutant p63, were previously described (62,63). The
DLX5-myc-tagged expression vectors were obtained from
OriGene, and previously used (58). The Q178P DLX5-myc
point mutation [based on the sequence in NM_005221.5 (18)]
was generated by site-directedmutagenesis in theDLX5-myc ex-
pression plasmid and sequence-verified (Bio-Fab Research,
Rome, Italy). The Pin1 si-RNA was previously described (37).
Cell cultures and transfections
The U2OS human osteosarcoma and the A431 human epidermoid
squamous carcinoma cell lines were maintained in Dulbecco’s
modified Eagle’s medium (D-MEM) and 10% fetal bovine serum.
For transfection, 50,000cellswere seeded into24-wellmulti-plates
and the next day transfectedwith Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions. The total amount of
transfected DNA (500 ng) was kept constant using empty vector
when necessary. After 24 h, cells were lysed and assayed for
western blot analysis (29). MG132 treatment was initiated the
day after transfection with 5 mM MG132 (Sigma) for 5 h. FGFs
treatments were initiated 20 h after transfection with 1 ng/ml of
FGF8 or FGF2 for 3 h.
Western blot analyses
Twenty-four hours after transfection, cells were lysed in 100 ml
of loading buffer (2% sodium dodecyl sulfate, 30% glycerol,
144 mM b-mercaptoethanol, 100 mM Tris–HCl pH 6.8 and
0.1% Bromo-Phenol Blue): extracts were separated on SDS–
10% polyacrylamide gel, transferred on nitrocellulose mem-
brane (Protran, Millipore) and incubated with the relative anti-
bodies and developed according to the manufacturer’s
instructions (GeneSpin). The following primary antibodies
were used: a-p63 (4A4, sc- 8431, Santa Cruz), a-actin mouse
monoclonal (A2066, Sigma), a-Pin1 mouse monoclonal (G9,
sc-46660, Santa Cruz),a-Pin1 rabbit polyclonal,a-phospho-ser
polyclonal (Invitrogen, 618100) and a phospho-thr polyclonal
(Cell Signaling, # 9381). As secondary antibodies, we used the
following: a-mouse secondary (sc-2005, Santa Cruz) and
a-rabbit secondary (sc-2030, Santa Cruz).
Co-immunoprecipitation
HaCaT cells (4× 106/150 mm plate) were treated with FGF8
(1 ng/ml) for 3 h and then harvested for the preparation of whole-
cell lysates using RIPA buffer [10 mM Tris–HCl pH 8, 2 mM
EDTA, 0.1% SDS, 0.1% sodium deoxycholate, 140 mM NaCl,
1× Triton, supplementedwith 1 mMphenylmethylsulfonyl fluor-
ide and protease inhibitors (all from Sigma)]. Cell lysates were
incubated on ice for 20 min., vortexed and centrifuged at
6600×g for 10 min to remove cell debris. Protein concentration
was determined with Bradford Reagent (Sigma). Three milli-
grams of cell lysate was incubated overnight at 48C with 3 mg
of anti-p63 (H-129, sc-8344, SantaCruz). The immunocomplexes
were collected by incubating with a mix of Protein A–Agarose
and Protein G–Sepharose (Sigma) overnight at 48C. The beads
were washed three times: the first wash with RIPA buffer and
the others with PBS. The beads were then resuspended in 2×
Lysis buffer, loaded directly on a 10% SDS–polyacrylamide
gel and subjected to western blot with the indicated antibodies.
mRNA quantification by Real-Time qPCR
Embryonic FLs and HLs were dissected from embryos at the
indicated age, in coldRNase-freePBS,undermicroscopic exam-
ination.Aminimumof three limbswere pooled, according to the
genotype and collected in Trizol (Invitrogen). Total RNA was
extracted with the TRI reagent (Sigma) and treated with
DNAse I (Ambion). Reverse-transcription and cDNA synthesis
were done using kits (Invitrogen), as previously reported (7,64).
Three nanograms of each cDNA samplewere used inReal-Time
qPCR analyses using SYBR green IQ reagent (Biorad) on T900
HT Fast Real Time PCR Sistem (Applied Biosystems). The
TATA-binding protein (TBP) and the GAPDH mRNAs were
used for normalization. Primer sequences are provided in Sup-
plementary Material, Table S1. Experiments were repeated
twice on independent samples; every point was done on bio-
logical duplicates. Analyses were performed with ABI 2.1 soft-
ware (Applied Biosystems).
Total RNA from U2OS cells was extracted using the TRI
reagent and treated with DNase-I (Ambion). One micrograms
of RNA was retrotranscribed with SuperScriptII (Invitrogen).
qPCR was performed using SYBR green IQ reagent (Biorad)
on the Rotor Gene machine. Primers were designed to amplify
regions of 80–120 bp in size. Tubulin and GAPDH mRNAs
were used for normalization. Experiments were repeated twice
on independent samples. Primer sequences are provided in Sup-
plementary Material, Table S1.
Chromatin immunoprecipitation
ChIP analyses were performed on sheared genomic DNA from
1 × 106 U2OS cells transfected with 12 mg of DLX5-myc or
DLX5-Q178P-myc vectors, or with the empty pcDNA3 vector
as control and immunoprecipitated with 5 mg of anti-myc-TAG
mouse monoclonal antibody (SantaCruz, sc-40) or 5 mg of anti-
Flag antibody (Sigma, F3165) as previously described (7). For
negative control, an irrelevant antibodywasused.The sequences
of theoligonucleotidesused for this analysis areprovided inSup-
plementary Material, Table S1).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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